Peter Libby

102PUBLICATIONS

526CO-AUTHORS

Haematological tumoursCardiology (incl. cardiovascular diseases)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (102)

Sort by Publication Date:

|Jul 03, 2026

Rethinking triglycerides in the management of ASCVD.

|May 21, 2026

Flow-mediated endothelial remodeling and inflammation drive developmental vascular susceptibility in ldlr loss of function.

|May 14, 2026

Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

|May 13, 2026

Preemptive cardioprotection with a small molecule in rodents that suppresses genes predictive of heart failure.

|Apr 23, 2026

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial.

|Apr 07, 2026

Gamut of Patients Referred to Cardiology for Question of Clonal Hematopoiesis.

Ohad Oren, Peter Libby

Pageof 17

Frequent Collaborators

Deepak L Bhatt

Pradeep Natarajan

Benjamin L Ebert

Alexander G Bick

Samuel C R Sherratt

R Preston Mason

Md Mesbah Uddin

Guo-Ping Shi

Masanori Aikawa

Matthias Nahrendorf

Frequent Collaborators

Deepak L Bhatt

Pradeep Natarajan

Benjamin L Ebert

Alexander G Bick